Snippet Search

Searching 11,975,612 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 9351 to 9375 of 9736 matching articles

Results per page:

... alone or in combination with 5-FU and  mitomycin 
Pancreatic Cancer
Pancreatic Cancer
Nieder, Carsten; Brunner, Thomas B.
-C. ...
... After 21 days, MSCs pretreated with  mitomycin 
Nanomolecular Diagnostics
Nanomolecular Diagnostics
Jain, Kewal K.
C still showed a large number of ...
... (e.g., doxorubicin, methotrexate,  mitomycin 
Antibody-Drug Conjugates: Can Coupling Cytotoxicity and Specificity Overcome Therapeutic Resistance?
Antibody-Drug Conjugates: Can Coupling Cytotoxicity and Specificity Overcome Therapeutic Resistance?
Drake, Penelope M.; Rabuka, David
, 5-fluorouracil, and the vinca alkaloids) ...
... Adriamycin, Bleomycin, Actinomycin D, and  Mitomycin 
Biology of Large Dose per Fraction Irradiation
Biology of Large Dose per Fraction Irradiation
Okunieff, Paul; Sundararaman, Srinath; Metcalfe, Su; Chen, Yuhchyau
C Antibiotics: intercalation into DNA where ...
... DNA damage in E. coli by exposure to  mitomycin 
Structure and variation of CRISPR and CRISPR-flanking regions in deleted-direct repeat region Mycobacterium tuberculosis complex strains
Structure and variation of CRISPR and CRISPR-flanking regions in deleted-direct repeat region Mycobacterium tuberculosis complex strains
Freidlin, Paul Jeffrey; Nissan, Israel; Luria, Anna; Goldblatt, Drora; Schaffer, Lana; Kaidar-Shwartz, Hasia; Chemtob, Daniel; Dveyrin, Zeev; Head, Steven Robert; Rorman, Efrat
C, UV light or cisplatin. ...
... Erlotinib, Lapatinib, Alkeran, Etoposide,  Mitomycin 
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial
Weber, Béatrice; Largillier, Rémy; Ray-Coquard, Isabelle; Yazbek, Gabriel; Meunier, Jérôme; Alexandre, Jérôme; Dauba, Jérôme; Spaeth, Dominique; Delva, Rémy; Joly, Florence; Pujade-Lauraine, Eric; Copel, Laure; on behalf of the GINECO group, France
, Hexastat, 5-FU, Ifosfamide, Methotrexate ...
... splenocytes treated with 100 μg/ml  mitomycin 
Auditory stimulation of opera music induced prolongation of murine cardiac allograft survival and maintained generation of regulatory CD4+CD25+ cells
Auditory stimulation of opera music induced prolongation of murine cardiac allograft survival and maintained generation of regulatory CD4+CD25+ cells
Uchiyama, Masateru; Jin, Xiangyuan; Zhang, Qi; Hirai, Toshihito; Amano, Atsushi; Bashuda, Hisashi; Niimi, Masanori
C (MMC; Kyowa Hakko, Osaka, Japan) for 30 ...
... hGH reduces sensitivity to treatment with  mitomycin 
The Contribution of Growth Hormone to Mammary Neoplasia
The Contribution of Growth Hormone to Mammary Neoplasia
Perry, Jo K.; Mohankumar, Kumarasamypet M.; Emerald, B. Starling; Mertani, Hichem C.; Lobie, Peter E.
C in several mammary carcinoma cell lines ...
... cells Modulation of drug efflux [72]  Mitomycin 
Nanotherapeutics in Multidrug Resistance
Nanotherapeutics in Multidrug Resistance
Han, Min; Gao, Jian-Qing
C Doxorubicin MDA-MB-435/LCC6/MDR1 cell ...
... radiation and the chemical mutagen  mitomycin 
Microwave Effects on DNA
Microwave Effects on DNA
Behari, Jitendra; Jindal, Tanu
C were studied by these authors using human ...
... treatment with the BCG and interferon alfa,  mitomycin 
Diseases of the Kidney
Diseases of the Kidney
Baumgarten, Margaret; Gehr, Todd W. B.; Carl, Daniel
, doxorubicin, thiotepa or gemcitabine ...
... certain alkylating agents such as CCNU and  mitomycin 
Clinical Exploitation of Hypoxia
Clinical Exploitation of Hypoxia
Higgins, Geoff S; Harris, Adrian L
C (Fiumicino et al. 2000). Probably the ...
... along 96 h (days 1–5 and 29–33) and  mitomycin 
Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients
Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients
Franco, Pierfrancesco; Arcadipane, Francesca; Ragona, Riccardo; Lesca, Adriana; Gallio, Elena; Mistrangelo, Massimiliano; Cassoni, Paola; Arena, Vincenzo; Bustreo, Sara; Faletti, Riccardo; Rondi, Nadia; Morino, Mario; Ricardi, Umberto
C (10 mg/m2) given as bolus (days 1 and ...
... of a cell-free medium containing 0.5 μg/ml  mitomycin 
Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties
Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties
Ha, Na Hee; Woo, Bok Hee; Kim, Da Jeong; Ha, Eun Sin; Choi, Jeom Il; Kim, Sung Jo; Park, Bong Soo; Lee, Ji Hye; Park, Hae Ryoun
(Sigma, St. ...
... associated with drugs (i.e., doxorubicin,  mitomycin 
Combined Therapies for the Treatment of Technically Unresectable Liver Malignancies: Bland Embolization and Radiofrequency Thermal Ablation within the Same Session
Combined Therapies for the Treatment of Technically Unresectable Liver Malignancies: Bland Embolization and Radiofrequency Thermal Ablation within the Same Session
Bonomo, Guido; Della Vigna, Paolo; Monfardini, Lorenzo; Orgera, Gianluigi; Chiappa, Antonio; Bianchi, Paolo Pietro; Zampino, Maria Giulia; Orsi, Franco
), and a longer delay between the two ...
... and other antibiotics (bleomycin,  mitomycin 
Tumor Development
Tumor Development
Banfalvi, Gaspar
C, actinomycin D). ...
... at least 28 days (or 6 weeks for  mitomycin 
Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer
Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer
Infante, Jeffrey R.; Patnaik, Amita; Verschraegen, Claire F.; Olszanski, Anthony J.; Shaheen, Montaser; Burris, Howard A.; Tolcher, Anthony W.; Papadopoulos, Kyriakos P.; Beeram, Muralidhar; Hynes, Scott M.; Leohr, Jennifer; Lin, Aimee Bence; Li, Lily Q.; McGlothlin, Anna; Farrington, Daphne L.; Westin, Eric H.; Cohen, Roger B.
-C or nitrosoureas) prior to dosing. ...
... favorable neuronal physiological functions.  Mitomycin 
Topographical control of cell-cell interaction in C6 glioma by nanodot arrays
Topographical control of cell-cell interaction in C6 glioma by nanodot arrays
Lee, Chia-Hui; Cheng, Ya-Wen; Huang, G Steven
C and retinoic acid (RA) have been shown to ...
... received neo-adjuvant CVA21 or low dose  mitomycin 
Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
Gulley, James L.; Repasky, Elizabeth A.; Wood, Laura S.; Butterfield, Lisa H.
C plus CVA21 prior to surgical removal. ...
... virginiae, DD494830, 494849-64; AB283030),  mitomycin 
Evolutionary flux of potentially bldA-dependent Streptomyces genes containing the rare leucine codon TTA
Evolutionary flux of potentially bldA-dependent Streptomyces genes containing the rare leucine codon TTA
Chandra, Govind; Chater, Keith F.
(S. lavendulae, 269387-468), ...
... activity, whereas cytotoxic agents, such as  mitomycin 
Adhesions after abdominal surgery: a systematic review of the incidence, distribution and severity
Adhesions after abdominal surgery: a systematic review of the incidence, distribution and severity
Okabayashi, Koji; Ashrafian, Hutan; Zacharakis, Emmanouil; Hasegawa, Hirotoshi; Kitagawa, Yuko; Athanasiou, Thanos; Darzi, Ara
C, can reduce adhesion formation via the ...
... culture reagents: Culture medium, FCS, PBS,  mitomycin 
Generation of Self-Peptides to Treat Systemic Lupus Erythematosus
Generation of Self-Peptides to Treat Systemic Lupus Erythematosus
Briand, Jean-Paul; Schall, Nicolas; Muller, Sylviane
-C (Sigma), and ACK ...
... ECM-coated dishes, and treated cells with  Mitomycin 
Muscarinic Receptor Agonists and Antagonists: Effects on Keratinocyte Functions
Muscarinic Receptor Agonists and Antagonists: Effects on Keratinocyte Functions
Grando, Sergei A.
C to inhibit proliferation. ...
... Nummuli sowie die topische Behandlung mit  Mitomycin 
Einführung
Einführung
Assadian, Ojan; Bialasiewicz, Alexander A.; Falke, Karen; Guthoff, R. F.; Kramer, Axel; Peschel, Sabine; Pleyer, Uwe; Seitz, Berthold; Steven, Philipp; Szentmáry, Nóra; Zhivov, Andrey
-C in Verbindung mit photorefraktiver ...
... NSb  Capecitabine 17 (58.6%) 17 (60.7%)    Mitomycin 
Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer
Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer
Park, In Hae; Ro, Jungsil; Lee, Keun Seok; Kim, Shi Nae; Yun, Young Ho; Nam, Byung Ho
14 (48.3%) 16 (57.1%)  Docetaxel 4 (13.8%) ...